A Relative Bioavailability Study of Bupropion Extended-Released 150 mg Tablets Under Fed Conditions

NCT00865371 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Abrika Bupropion 150 mg Extended-Released Tablet
DRUG: Wellbutrin SR® 150 mg Extended-Release Tablet, single dose

Sponsor

Actavis Inc.